藥物成份
共有 21387 個藥物成份
1, 25-(OH)2D NSB Buffer: Potassium phosphate gelatin buffer containing ProClin 300 (< 0.2%).1, 25-(OH)2D 0 Calibrator: Phosphate buffer containing bovine serum proteins and ProClin 300 (<0.2%).1, 25-(OH)2D3 Calibrators (1-5): Five lyophilized (1, 25-(OH)2D3) calibrators at concentrations ranging from 5-200 pg/ml containing human serum and ProClin 300 (<0.2%).1, 25-(OH)2D Antiserum: Rabbit anti-1, 25-(OH)2D serum diluted in phosphate-gelatin buffer containing ProClin 300 (<0.2%).125I 1, 25-(OH)2D3: Radio-iodinated 1, 25-(OH)2D3 analogue diluted in an ethylene glycol phosphate buffer.1, 25-(OH)2D3 Pretreatment solution: Potassium phosphate buffer.1, 25-(OH)2D Controls: Level 1 (Normal), Level 2 (Elevated): Processed human serum pool, containing ProClin 300 (<0.2%), spiked with the appropriate amounts of 1, 25-(OH)2D to obtain control concentrations within the specified ranges.Goat Anti-Rabbit (GAR) Precipitating Complex: Normal rabbit serum, pre-precipitated with goat anti-rabbit serum and polyethylene glycol (
1. ANCA slides, ethanol-fixed human neutrophil substrate slides, 6 wells/slide, with desiccant.\n2. Anti-Human IgG Conjugate (Goat), fluorescein labeled in buffer containing Evans Blue and 0.09% sodium azide, 4mL.\n3. cANCA Positive, 1 vial of buffer containing 0.09% sodium azide and human serum antibodies to cANCA antigens, prediluted, 0.5mL.\n4. pANCA Positive, 1 vial of buffer containing 0.09% sodium azide and human serum antibodies to pANCA antigens, prediluted, 0.5mL.\n5. IFA System Negative Control, 1 vial of buffer containing 0.09% sodium azide and no human serum antibodies to ANCA, prediluted, 0.5mL.\n6. PBS Concentrate (40x), sufficient for 1000 mL.\n7. Mounting Medium, 0.09% sodium azide, 7mL.\n8. Coverslips
1. Glucose: Glucose oxidase (GOD) …………………………...…700 I.U. \n Peroxidase (POD) ……………………………..…….175 P.U.\n4-Aminoantipyrine (4-AAP) ………………………..14.0 mg\n1- Naphthol-3, 6-disulfonic acid, disodium salt….. 14.0 mg \n2. Protein: Tetrabromophenol blue (TBPB) ………………….…..0.35 mg \n3. Bilirubin: 2-Methyl-5-nitroaniline …………………………….1.9 mg\nSodium nitrite ……………………………………….1.0 mg\n4. Urobilinogen: 3, 3-Dimethoxy-4, 4-biphenylbis (diazonium tetrafluoroborate)…………………0.16mg\n5. Creatinine: 2,6-Dichloro-4-hydroxy-3,3-dimethyl-3-sulfofuchsone-5,5-dicarboxylic acid trisodium salt………………………………………………………………………0.34mg \nPalladium (Ⅱ) chloride……………………………………………………...……0.10mg\n6. PH: Bromocresol green ………………………………..…….0.07 mg\nBromoxylenol blue ……………………………………….0.72 mg \n7. Blood: Cumene hydroperoxide (CHP) ………………….……30.0 mg\n3, 3, 5, 5-Tetramethylbenzidine (TMBZ) …………..….15.0 mg\n8. Ketones: Sodium nitroprusside ………………………………12.0 mg\n9. Nitrite: Sulfanilamide……………………………………….. 3.9 mg\nN-1-Naphthylethylenediamine dih
1. IGF-1 Standards (lyophilized): 6 vials, labeled A-F, containing concentrations of approximately 0-8-30-100-300-1000 ng/mL (1.1-130 nmol/L) of IGF I in a protein-based (BSA) buffer.\n2. Anti-IGF-1 [I-125] Reagent (red): 1 bottle, 22 mL, containing <370 kBq of I-125-labeled anti-IGF-1 in a protein-based (BSA) buffer.\n3. Anti-IGF-1 Coated Tubes (metallic light green rim): 100 tubes with Anti-IGF-1 immunoglobulin immobilized to the inside walf for each tube.\n4. Sample Diluent: 1 bottle, 105 mL, containing sample buffer.\n5. Wash Concentrate B 25X: 1 bottle, 60 mL, containing buffer with a non-ionic detergent.\n6. IGF-1 Controls (Lyophilized): 2 vials, Level I and Level II, containing low and high concentrations of IGF-1 in a protein-based (BSA) buffer.\n